Fig. 6From: Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse gliomaFunctional and pathway analysis of antisense lncRNA WDFY3-AS2 in glioma. a GO annotations based on the top 2000 genes positively and negatively associated with WDFY3-AS2. b KEGG pathway analysis based on the top 2000 genes positively and negatively associated with WDFY3-AS2. c, d GSEA analysis based on the median value of WDFY3-AS2 expression levelBack to article page